NL7108301A - - Google Patents

Info

Publication number
NL7108301A
NL7108301A NL7108301A NL7108301A NL7108301A NL 7108301 A NL7108301 A NL 7108301A NL 7108301 A NL7108301 A NL 7108301A NL 7108301 A NL7108301 A NL 7108301A NL 7108301 A NL7108301 A NL 7108301A
Authority
NL
Netherlands
Application number
NL7108301A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7108301A publication Critical patent/NL7108301A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NL7108301A 1970-06-17 1971-06-17 NL7108301A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2944170 1970-06-17

Publications (1)

Publication Number Publication Date
NL7108301A true NL7108301A (fr) 1971-12-21

Family

ID=10291612

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7108301A NL7108301A (fr) 1970-06-17 1971-06-17

Country Status (10)

Country Link
US (1) US3862195A (fr)
BE (1) BE767570A (fr)
CA (1) CA943539A (fr)
CH (1) CH528495A (fr)
DE (1) DE2129301A1 (fr)
ES (1) ES391857A1 (fr)
FR (1) FR2100770B1 (fr)
GB (1) GB1355663A (fr)
IT (1) IT1037033B (fr)
NL (1) NL7108301A (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208032A (en) * 1988-07-15 1993-05-04 Rutgers, The State University Of New Jersey Increasing the growth of turkeys using implant of 19-nortestosterone
US6011027A (en) * 1999-02-18 2000-01-04 Lpj Research, Inc. Use of 19-nor-4-androstenediol to increase 19-nortestosterone levels in humans
AU2006211907B2 (en) * 2005-02-04 2011-09-08 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Nandrolone 17beta-carbonates
BR112020007673A2 (pt) * 2017-10-19 2020-10-13 Evestra, Inc. contraceptivos pró-fármaco de progestina de ação prolongada

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB753793A (en) * 1953-07-17 1956-08-01 Schering Corp Aryloxy esters of testosterone, and therapeutic compositions thereof
GB1189217A (en) * 1966-07-28 1970-04-22 Takeda Chemical Industries Ltd 09-nor-Testosterone Phenoxyacetate and 6-Methyl Derivatives thereof
US3523126A (en) * 1967-12-13 1970-08-04 Du Pont Testosterone and 19-nortestosterone(4'-methylbicyclo(2,2,2)octane - 1' - methyl)carbonate and selected derivatives

Also Published As

Publication number Publication date
FR2100770B1 (fr) 1975-01-17
DE2129301A1 (de) 1971-12-23
IT1037033B (it) 1979-11-10
BE767570A (fr) 1971-10-18
FR2100770A1 (fr) 1972-03-24
GB1355663A (en) 1974-06-05
CA943539A (en) 1974-03-12
US3862195A (en) 1975-01-21
CH528495A (fr) 1972-09-30
ES391857A1 (es) 1973-07-01

Similar Documents

Publication Publication Date Title
CS167314B2 (fr)
FR2083470A1 (fr)
FR2088259B1 (fr)
FR2077093A5 (fr)
FR2084087A5 (fr)
FR2077189A1 (fr)
FR2085951B1 (fr)
FR2100770B1 (fr)
FR2076786A5 (fr)
FR2079564A5 (fr)
FI49359B (fr)
FR2077066A5 (fr)
FR2054194A5 (fr)
FR2088641A5 (fr)
FR2088590A5 (fr)
DE2031329C3 (fr)
FI47462B (fr)
FR2088901A5 (fr)
JPS5040252B1 (fr)
FR2086096B1 (fr)
FR2075554A5 (fr)
FR2088670A5 (fr)
FR2076751A5 (fr)
DE2112846C3 (fr)
FI45396B (fr)